Belcher Pharmaceuticals do Brasil and the Federal Centre for Animal Health (FGBI ARRIAH) are pleased to announce their joint participation at SIAVS 2024, one of the most important events in the Brazilian agribusiness sector. The event will take place from August 6 to 8, 2024, at Anhembi Parque in São Paulo.
Founded in Brazil in 2011, Belcher Pharmaceuticals do Brasil is a subsidiary of Belcher Pharmaceuticals, headquartered in Tampa, Florida, United States, which has more than 50 years of experience in the global market. Belcher is dedicated to excellence in product development to meet the specific needs of the Brazilian market, distributing innovative solutions for the pharmaceutical, diagnostic, food and hospital sectors.
FGBI ARRIAH is a renowned testing center and scientific institution in Russia with more than 65 years of history. Internationally recognized for its advanced research and development of biological products for animals, including vaccines and diagnostic kits, ARRIAH plays a crucial role in ensuring animal health and food safety.
International Certifications and Recognitions of FGBI ARRIAH
- Regional Reference Laboratory of WOAH for Foot and Mouth Disease in Eastern Europe, Central Asia and Transcaucasia.
- WOAH Collaborating Centre for Diagnosis and Control of Animal Diseases in Eastern Europe, Central Asia and Transcaucasia.
- WOAH Reference Laboratory for Highly Pathogenic Avian Influenza, Low Pathogenic Avian Influenza in poultry and Newcastle Disease.
- FAO Reference Centre for Foot and Mouth Disease.
- FAO Reference Centre for Zoonotic Coronaviruses.
Durante a SIAVS 2024, a Belcher Pharmaceuticals do Brasil e o FGBI ARRIAH apresentarão um amplo e robusto portfólio de produtos, destacando inovações e tecnologias de ponta em saúde animal. Este evento será uma oportunidade única para ambas as empresas fortalecerem sua presença no mercado e estabelecerem parcerias estratégicas de cooperação comercial e científica com os setores privado e público.
Quotes
Emanuel Catori, CEO of Belcher Pharmaceuticals do Brasil:
“We are excited to participate in SIAVS 2024 alongside FGBI ARRIAH. Our partnership represents an important milestone and demonstrates our joint commitment to innovation and quality in animal health.”
Belcher Pharmaceuticals do Brasil and FGBI ARRIAH invite all SIAVS 2024 participants to visit their booth to learn more about their innovations and collaboration opportunities.
Press Contacts
Name: Rafael Crivellari
Phone: 41 99796 4407
E-mail: coordenacao@belcher.com.br
Website www.belcher.com.br/siavs
Social Media www.instagram.com/
